Matthew David
2023
In 2023, Matthew David earned a total compensation of $1M as Chief Financial Officer at CorMedix, a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,000 |
|---|---|
| Option Awards | $433,875 |
| Salary | $389,135 |
| Other | $52,140 |
| Total | $1,031,150 |
David received $433.9K in option awards, accounting for 42% of the total pay in 2023.
David also received $156K in non-equity incentive plan, $389.1K in salary and $52.1K in other compensation.
Rankings
In 2023, Matthew David's compensation ranked 1,160th out of 2,918 executives tracked by ExecPay. In other words, David earned more than 60.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,160 out of 2,918 | 60th |
Division Manufacturing | 697 out of 1,608 | 57th |
Major group Chemicals And Allied Products | 466 out of 901 | 48th |
Industry group Drugs | 455 out of 864 | 47th |
Industry Pharmaceutical Preparations | 313 out of 622 | 50th |
Source: SEC filing on October 8, 2024.
David's colleagues
We found three more compensation records of executives who worked with Matthew David at CorMedix in 2023.